Agoraphobia
Understanding Agoraphobia diagnosis, medical coding, and clinical documentation. Learn about the fear of open spaces and fear of public places, including symptoms, treatment, and DSM-5 criteria. Find resources for healthcare professionals on Agoraphobia diagnosis and best practices for accurate medical coding.
Anxiety disorder marked by fear of situations where escape might be difficult or help unavailable if panic occurs.
Avoidance of public transport, open spaces, crowds, being outside home alone. Panic attacks, anticipatory anxiety.
Therapy (CBT, exposure), support groups, primary care, mental health clinics.
ICD-10 Code Families
Complete code families applicable to F40.00
When to use each related code
| Description | When to use |
|---|---|
| Fear of situations where escape is difficult. | Use for marked fear/anxiety in 2+ agoraphobic situations, causing avoidance. Impairment and distress key. |
| Fear of social scrutiny leading to avoidance. | Use for fear of negative evaluation in social situations. Specify if performance only. Impairment crucial. |
| Excessive worry, difficult to control. | Use when worry is pervasive, excessive, and difficult to control for 6+ months. Physical symptoms often present. |
Best-practice checklist
- ✓Agoraphobia (ICD-10 F40.00) diagnosis documented
- ✓Symptoms impacting daily life described
- ✓Onset and duration of Agoraphobia noted
- ✓Specific feared situations/places listed
- ✓Severity of fear/avoidance documented
Common pitfalls to avoid
Coding without specific situational triggers or manifestations risks downcoding to a less specific, lower-paying code. Document details for accurate reimbursement.
Agoraphobia often coexists with panic disorder. Failure to code both diagnoses separately leads to underreporting severity and lost revenue.
Misdiagnosis with other anxiety disorders like social phobia or specific phobias can impact treatment and claim validity. Ensure clear documentation supports agoraphobia.
Best-practice tips
- 01Gradual exposure therapy, CDI: F40.00
- 02Relaxation techniques (CBT), ICD-10: F40.00
- 03Support groups, peer counseling, DSM-5: 300.22
- 04Mindfulness exercises for anxiety, SNOMED: 197480006
- 05Medication management by psychiatrist
Step-by-step checklist
- 1
1. Marked fear/anxiety re: 2+ situations: public transport, open spaces, enclosed spaces, crowds, being outside home alone.
- 2
2. Avoids these situations due to fear of panic attack or other incapacitating/embarrassing symptoms.
- 3
3. Fear/anxiety out of proportion to actual danger.
- 4
4. Persistent, typically lasting 6+ months.
- 5
5. Clinically significant distress/impairment. Rule out medical/substance factors. ICD-10-CM: F40.00
Ready-to-paste narrative
Patient presents with symptoms consistent with a diagnosis of Agoraphobia (ICD-10-CM F40.00). The patient reports experiencing marked fear or anxiety in at least two of the following five situations: using public transportation, being in open spaces, being in enclosed spaces, standing in line or being in a crowd, and being outside of the home alone. The patient avoids these situations due to thoughts that escape might be difficult or help might not be available in the event of developing panic-like symptoms or other incapacitating or embarrassing symptoms. The patient's fear or anxiety is out of proportion to the actual danger posed by the agoraphobic situations and to the sociocultural context. The fear, anxiety, or avoidance is persistent, typically lasting for six months or more, and causes clinically significant distress or impairment in social, occupational, or other important areas of functioning. Differential diagnoses considered include panic disorder, social anxiety disorder, specific phobia, separation anxiety disorder, and post-traumatic stress disorder. The patient's symptoms were determined to not be better explained by another medical condition or the physiological effects of a substance. Treatment plan includes cognitive behavioral therapy (CBT) focusing on exposure therapy and relaxation techniques, in addition to consideration of pharmacotherapy with selective serotonin reuptake inhibitors (SSRIs) for anxiety management. Patient education on agoraphobia, its prognosis, and the importance of treatment adherence was provided. Follow-up appointment scheduled in two weeks to assess treatment response and adjust plan as needed. Medical coding for this encounter includes F40.00 for the primary diagnosis of agoraphobia.
Common questions and answers
How can I differentiate between Agoraphobia and Panic Disorder in clinical practice, considering their frequent comorbidity and overlapping symptoms like fear of public places or open spaces?+
While Agoraphobia and Panic Disorder often co-occur, differentiating them is crucial for effective treatment. Panic Disorder is characterized by recurrent unexpected panic attacks, while Agoraphobia involves a marked fear or anxiety about two or more of the following situations: using public transportation, being in open spaces, being in enclosed spaces, standing in line or being in a crowd, or being outside of the home alone. The key distinction is that individuals with Agoraphobia fear these situations because they believe escape might be difficult or help might not be available in the event of panic-like symptoms or other incapacitating or embarrassing symptoms (e.g., fear of falling in the elderly; fear of incontinence). A person can have Agoraphobia without a history of Panic Disorder. Explore how a detailed clinical interview, including assessment of the feared situations and the specific concerns associated with them, can help distinguish these conditions and tailor treatment accordingly.
What are evidence-based, first-line treatment strategies for Agoraphobia, specifically focusing on pharmacotherapy and psychotherapy approaches appropriate for varying levels of severity?+
Evidence-based treatment for Agoraphobia typically involves a combination of psychotherapy and pharmacotherapy. Cognitive Behavioral Therapy (CBT), particularly exposure therapy, is considered the first-line psychotherapy approach. Exposure therapy involves gradually confronting feared situations, helping patients learn that their anxiety is manageable and disconfirming their catastrophic predictions. For pharmacotherapy, Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) are frequently used as first-line medications. For moderate to severe cases, short-term use of benzodiazepines may be considered to manage acute anxiety, but long-term use should be avoided due to the risk of dependence. The choice of treatment should be individualized based on the severity of symptoms, patient preference, and comorbid conditions. Consider implementing a stepped-care approach, starting with CBT and adding medication if necessary. Learn more about the latest clinical guidelines for Agoraphobia treatment to stay informed about best practices.
When assessing a patient for potential Agoraphobia diagnosis, what specific questions should clinicians ask to accurately identify the core fear of open spaces or public places and differentiate it from other anxiety disorders such as social anxiety disorder?+
To accurately diagnose Agoraphobia, clinicians should ask targeted questions beyond the general fear of open or public spaces. Inquire about the specific situations that evoke fear or anxiety (e.g., crowded shopping malls, public transportation, standing in line). Importantly, explore *why* the patient fears these situations. Do they worry about having a panic attack? Are they concerned about being trapped or unable to escape if they become unwell? Do they fear embarrassment or scrutiny from others? These questions can help differentiate Agoraphobia from Social Anxiety Disorder, where the primary fear is negative evaluation by others. For example, someone with Agoraphobia may fear being in a crowd because they worry about having a panic attack and being unable to escape, whereas someone with Social Anxiety Disorder may fear being in a crowd because they worry about being judged or humiliated. Explore how detailed questioning about the nature of the fear, the specific feared situations, and the associated concerns can lead to a more accurate diagnosis and inform appropriate treatment strategies.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.